Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Material (Hydroxyethyl Cellulose, Hydroxypropyl Cellulose, Polyacrylic Resins, Xanthan Gum, Carboxymethyl Cellulose, Hyaluronic acid, Alginate, Collagen, Hybrid), By Formulation, By Route of Administration, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031
Segmentation of Hydrogel-based Drug Delivery System Market-
Hydrogel-based Drug Delivery System Market By Material-
- Hydroxyethyl Cellulose
- Hydroxypropyl Cellulose
- Polyacrylic Resins
- Xanthan Gum
- Carboxymethyl Cellulose
- Hyaluronic acid
- Alginate
- Collagen
- Hybrid
- Others
Hydrogel-based Drug Delivery System Market By Formulation-
- Tablets
- Gels
- Films
- Suppositories
- Solutions
- Dressings
Hydrogel-based Drug Delivery System Market By Route of Administration-
- Oral
- Buccal
- Rectal
- Vaginal
- Ocular
- Transdermal
- Injectable
Hydrogel-based Drug Delivery System Market By Distribution Channel-
- Hospitals
- Specialty Clinics
- Retail Pharmacy Chains
- Drug Stores
- Online Sales Channels
Hydrogel-based Drug Delivery System Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Hydrogel-based Drug Delivery Market Snapshot
Chapter 4. Global Hydrogel-based Drug Delivery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Material Estimates & Trend Analysis
5.1. By Material & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Material:
5.2.1. Hydroxyethyl Cellulose
5.2.2. Hydroxypropyl Cellulose
5.2.3. Polyacrylic Resins
5.2.4. Xanthan Gum
5.2.5. Carboxymethyl Cellulose
5.2.6. Hyaluronic acid
5.2.7. Alginate
5.2.8. Collagen
5.2.9. Hybrid
5.2.10. Others
Chapter 6. Market Segmentation 2: By Formulation Estimates & Trend Analysis
6.1. By Formulation & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Formulation:
6.2.1. Tablets
6.2.2. Gels
6.2.3. Films
6.2.4. Suppositories
6.2.5. Solutions
6.2.6. Dressings
Chapter 7. Market Segmentation 3: By Route of Administration Estimates & Trend Analysis
7.1. By Route of Administration & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Route of Administration:
7.2.1. Oral
7.2.2. Buccal
7.2.3. Rectal
7.2.4. Vaginal
7.2.5. Ocular
7.2.6. Transdermal
7.2.7. Injectable
Chapter 8. Market Segmentation 4: by Distribution Channel Estimates & Trend Analysis
8.1. by Distribution Channel & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
8.2.1. Hospitals
8.2.2. Specialty Clinics
8.2.3. Retail Pharmacy Chains
8.2.4. Drug Stores
8.2.5. Online Sales Channel
Chapter 9. Hydrogel-based Drug Delivery Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.1.2. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.1.3. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.1.4. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.1.5. North America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.2.2. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.2.3. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.2.4. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.2.5. Europe Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.3.2. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.3.3. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.3.4. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.3.5. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.4.2. Asia Pacific Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.4.3. Latin America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.4.4. Latin America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.4.5. Latin America Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Material, 2024-2031
9.5.2. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
9.5.3. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
9.5.4. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
9.5.5. Middle East & Africa Hydrogel-based Drug Delivery Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. AstraZeneca Plc.
10.2.2. Columbia Laboratories Inc.
10.2.3. Mylan
10.2.4. Teva Pharmaceuticals USA Inc.
10.2.5. Blairex Laboratories Inc.
10.2.6. ARx LLC.
10.2.7. Endo International plc
10.2.8. BioDelivery Sciences International Inc.
10.2.9. Indivior PLC
10.2.10. GSK Plc
10.2.11. Pfizer Inc.
10.2.12. Aquestive Therapeutics Inc.
10.2.13. ZIM LABORATORIES LIMITED
10.2.14. IntelGenx Corp.
10.2.15. NEXGEL
10.2.16. Bliss GVS Pharma Ltd.
10.2.17. Teika Pharmaceutical Co. Ltd.
10.2.18. Medherant Limited
10.2.19. Galderma
10.2.20. Johnson & Johnson
10.2.21. Bausch and Lomb
10.2.22. Ferring B.V
10.2.23. Ocular Therapeutix Inc
10.2.24. 3M company
10.2.25. Coloplast A/S
10.2.26. AD Surgical
10.2.27. AdvaCare Pharma®
10.2.28. McKesson
10.2.29. KIKGEL
10.2.30. Scapa Healthcare
10.2.31. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
The Hydrogel-based Drug Delivery System Market Size is valued at USD 7.98 billion in 2023 and is predicted to reach USD 13.43 billion by the year 2031
The Hydrogel-based Drug Delivery System Market is expected to grow at a 6.8% CAGR during the forecast period for 2024-2031.
AstraZeneca Plc, Columbia Laboratories Inc, Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDeli